Position in TAK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,320,920
+$206,610 QoQ
Shares Held
71,324
-0.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026XTX Topco Ltd holds $27,950,471 across 45 Drug Manufacturers - Specialty & Generic names. TAK ranks #8 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
379,350 | $3,797,293 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
28,525 | $2,193,572 | |
| 3 | PCRX |
Pacira BioSciences, Inc.
|
91,114 | $2,059,176 | |
| 4 | VTRS |
Viatris Inc
|
144,138 | $1,947,304 | |
| 5 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
87,736 | $1,718,748 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
26,428 | $1,566,387 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
25,626 | $1,324,607 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
71,324 | $1,320,920 |
All Filings in TAK
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,320,920 | 71,324 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,114,310 | 71,476 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $194,609 | 13,293 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $324,274 | 24,492 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $956,806 | 67,286 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $584,991 | 42,116 | Shares | Defined | 2024-05-13 | |
| 2023-06-30 | $303,658 | 19,329 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $157,360 | 11,208 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||